IN SITU PHOTO CROSSLINKED COLLAGEN/GF FOR BONE REPAIR

Information

  • Research Project
  • 2538809
  • ApplicationId
    2538809
  • Core Project Number
    R43AR044610
  • Full Project Number
    1R43AR044610-01A1
  • Serial Number
    44610
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/25/1998 - 26 years ago
  • Project End Date
    1/24/2000 - 25 years ago
  • Program Officer Name
  • Budget Start Date
    8/25/1998 - 26 years ago
  • Budget End Date
    1/24/2000 - 25 years ago
  • Fiscal Year
    1998
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    8/24/1998 - 26 years ago
Organizations

IN SITU PHOTO CROSSLINKED COLLAGEN/GF FOR BONE REPAIR

Several dental and orthopedic conditions would benefit from an improved procedure for promoting bone regeneration or augmentation. The goal of this project is to develop a biodegradable osteoinductive preparation that will promote spatially-controlled bone regeneration in vivo. The preparation will consist of an osteoinductive growth factor and a collagen carrier, with the collagen carrier being derivatized by addition of photoactivatible groups. The preparation will be a viscous liquid when placed in the bone defect and will both solidify and bond to the remaining bone after being illuminated by a standard dental composite curing lamp. The collagen carrier will be a combination of insoluble particles of type I collagen (which will biodegrade slowly and provide an osteoconductive surface for migration and differentiation of osteoblasts) and photoderivatized type I collagen (which will crosslink to solidify the preparation). Three different photochemisty approaches will be compared for producing collagen gels, with the different variants being evaluated in vitro for strength and cytotoxicity, in rat implants as an inexpensive screening assay for bone formation in vivo, and in surgically-created bone defects in dogs as an efficacy test for bone regeneration around the roots of teeth. An osteoinductive collagen/GF preparation that can be crosslinked in vivo is expected to be used for several applications, including: 1) restoration of bone loss around the roots of teeth or dental implants, 2) augmentation of facial bones, 3) filling of defects in compound fractures, and 4) stabilization of vertebrae after spinal fusion. PROPOSED COMMERCIAL APPLICATION: An osteoinductive collagen/growth factor preparation that can be crosslinked in vivo should have broad application in several areas, including: 1) restoration of bone loss around the roots of teeth or dental implants, 2) augmentation of facial bones, 3) filling of defects in compound fractures, and 4) stabilization of vertebrae after spinal fusion.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R43
  • Administering IC
    AR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG4
  • Study Section Name
  • Organization Name
    SURMODICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    EDEN PRAIRIE
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55344
  • Organization District
    UNITED STATES